Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Neuropathy with IgM Gammopathy: Incidence, Characteristics and Management, a Rory Morrison W.M.U.K Registry Analysis

Oliver Tomkins, BMBS,MRCP, Jindriska Lindsay, FRCPath, Stephen Keddie, MRCP, Aisling Carr, PhDFRCP, Helen McCarthy, PhD FRCPath, Dima El-Sharkawi, MBBS, FRCPath, PhD, Charalampia Kyriakou, MD PhD, Kirsty Cuthill, FRCPath,MBBS,MRCP,PhD, Guy Pratt, FRCPath, Ali Rismani, FRCPath, Michael P Lunn, Shirley D'Sa, MD FRCPath

Blood (2020) 136 (Supplement 1): 1–2.

https://doi.org/10.1182/blood-2020-136558

Published: 2020

Journal Articles

Bendamustine Plus Rituximab for the Treatment of Waldenström Macroglobulinaemia: Patient Outcomes and Impact of Bendamustine Dosing

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-140774

Published: 2020

Journal Articles

High-Dose Methotrexate Based Therapy for the Treatment of Bing Neel Syndrome

Suzanne O Arulogun, MBBS, Michael P Lunn, Chandrashekar Hoskote, Aisling Carr, PhDFRCP, Oliver Tomkins, BMBS,MRCP, Ali Rismani, FRCPath, Ashutosh D. Wechalekar, Shirley D'Sa, MD FRCPath

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-141302

Published: 2020

Journal Articles

Effective Treatment of Cold Agglutinin Disease/Cold Agglutinin Syndrome with Ibrutinib: An International Case Series

Marit Jalink, Sigbjørn Berentsen, Jorge J. Castillo, MD, Steven Treon, Bruno Fattizzo, MD, Ramona Cassin, MD, Masja De Haas, Andrea Patriarca, MD, Shirley D'Sa, MD FRCPath, Josephine M.I Vos

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-139131

Published: 2020

Journal Articles

Focal, Symptomatic Bone Marrow Lesions in Waldenström Macroglobulinaemia Characterised By Dense Infiltration with Lymphoplasmacytic Lymphoma: A Newly Defined Indication for Systemic Treatment

Suzanne Arulogun, Maaz Ali Abbasi, Sabine Pomplun, Aideen Therese O'Neill, FRCPath, Simon Wan, Irfan Kayani, MBBS, BSc, MSc, FRCP, Shirley D'Sa, MD FRCPath

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-138716

Published: 2020

Journal Articles

Whimsical (Waldenstrom's Macroglobulinemia Study Involving CArt-wheeL): A Global Patient-Derived Data Registry Capturing Treatment, Quality of Life and COVID-19 Data

Ibrahim Tohidi-Esfahani, MBBS,FRACP,FRCPA, Andrew Warden, Elena Malunis, Peter Liburdi deNardis, Javier Haurat, Marita Black, Stephen Opat, MBBS (Hons), FRACP, FRCPA, Shirley D'Sa, MD FRCPath, Marie José Kersten, MD PhD, Ruth Spearing, MD, Maria Lia Palomba, Adam J Olszewski, MD, Carl Harrington, Clare Scott, MBBS PhDFRACP, Judith Trotman, FRACP

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-138945

Published: 2020

Journal Articles

Encouraging Clinical Outcomes for Lymphoma Patients Participating in Early Phase Clinical Trials in the Current Era: A Single Institution and a Global Perspective

Jenny O'Nions, MBBChir, PhD MRCP, FRCPath, Anna Cowley, MBBS, BSc, MRCP, FRCPath, Hakim-Moulay Dehbi, PhD, Dima El-Sharkawi, MBBS BSc FRCPath MD, Shirley D'Sa, MD FRCP, FRCPath, Kirit M. Ardeshna, MA MDFRCP FRCPath, Rakesh Popat, MBBS, BSc, MRCP, FRCPath, PhD, William Townsend, MD FRCPath

Blood (2018) 132 (Supplement 1): 4227.

https://doi.org/10.1182/blood-2018-99-118497

Published: 2018

Journal Articles

Outcomes of Stratification to ASCT or Not Based on Depth of Response: Results of a Phase 2 Trial Assessing the Impact of Minimal Residual Disease (MRD) in Multiple Myeloma Patients with Deferred ASCT (PADIMAC)

Blood (2017) 130 (Supplement 1): 1864.

https://doi.org/10.1182/blood.V130.Suppl_1.1864.1864

Published: 2017

Journal Articles

Long Term Efficacy, Safety and PK/PD Profile of the Anti-C1s Antibody (BIVV009) in Primary Cold Agglutinin Disease Patients

Ulrich Jaeger, MD, Shirley D'Sa, MD FRCP, FRCPath, Christian Schoergenhofer, MD, Johann Bartko, MD, Christian Sillaber, MD, Petra Jilma-Stohlawetz, MD, Michael Fillitz, MD, Thomas Schenk, MD, Gary Patou, MD, Sandip Panicker, PhD, Graham C Parry, PhD, James C Gilbert, MD, Bernd Jilma, MD

Blood (2017) 130 (Supplement 1): 703.

https://doi.org/10.1182/blood.V130.Suppl_1.703.703

Published: 2017

Journal Articles

A Seven Gene Signature to Distinguish Bortezomib- and Lenalidomide-Responsive Myeloma: Rnaseq from the Padimac Study

Blood (2017) 130 (Supplement 1): 267.

https://doi.org/10.1182/blood.V130.Suppl_1.267.267

Published: 2017

Journal Articles

Whimsical (Waldenström's Macroglobulinemia Study Involving CArt-wheeL): Empowering Patients Internationally to Contribute Patient-Derived Data for Observational Research

Ibrahim Tohidi-Esfahani, B MD, Andrew Warden, Peter deNardis, Elena Malunis, Shirley D'Sa, MD FRCP, FRCPath, Marie Jose Kersten, MD PhD, Maria Lia Palomba, MD, Ruth Spearing, MD, Loic Ysebaert, MD PhD, Sheeba K. Thomas, MD, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Clare Scott, MBBS PhDFRACP, Carl Harrington, Judith Trotman, FRACP

Blood (2017) 130 (Supplement 1): 1502.

https://doi.org/10.1182/blood.V130.Suppl_1.1502.1502

Published: 2017

Journal Articles

Whole Body (WB) MRI in Newly Diagnosed Multiple Myeloma (MM): Fat Fraction Changes at 8 Weeks Predict Response to Induction with Bortezomib Regimens

Arash Latifoltojar, MB BS, MSc, MPhil, Kwee L Yong, MBChB, PhD, Margaret Hall-Craggs, BA, MB BS, MD, Neil Rabin, MB,BS, PhD, Rakesh Popat, MBBS, PhD, Alan Bainbridge, Magdalena Sokolska, Nikolaos Dikaios, Shirley D'Sa, MD FRCP, FRCPath, Ali Rismani, MBBS, Shonit Punwani, Mb BS, BSc, PhD

Blood (2015) 126 (23): 1850.

https://doi.org/10.1182/blood.V126.23.1850.1850

Published: 2015

Journal Articles

Subcutaneous PAD As Induction Therapy for Patients with Newly Diagnosed Myeloma: A Phase 2 Trial Assessing the Impact of Minimal Residual Disease (MRD) in Patients with Deferred Autologous Stem Cell Transplantation (PADIMAC)

Blood (2014) 124 (21): 4745.

https://doi.org/10.1182/blood.V124.21.4745.4745

Published: 2014

Journal Articles

Single Centre Analysis Of Autologous Stem Cell Transplant Outcomes In Multiple Myeloma In 338 Consecutive Patients: Maintenance/Consolidation Is Associated With Superior Survival, But Early Relapse Is The Single Most Important Predictor Of Survival and May Override Genetic Risk

Paul M Maciocia, MRCP, Nicholas Counsell, Antonia Bird, Laura Percy, Sally Moore, BSc, FRPATH, FRCP, MBBS, Neil Rabin, Shirley D'Sa, MD, Manuel Rodriguez-Justo, Kwee L Yong, PhD

Blood (2013) 122 (21): 2159.

https://doi.org/10.1182/blood.V122.21.2159.2159

Published: 2013

Journal Articles

An Alternate Day Dosing Strategy for Lenalidomide in Multiple Myeloma Improves Cost-Effectiveness Whilst Maintaining Efficacy,

Rakesh Popat, Jenny Dickson, Iftekhar Khan, Simon Cheesman, Laura Percy, Sally Moore, Shirley D'Sa, MD, Neil Rabin, Kwee Yong, PhD

Blood (2011) 118 (21): 4201.

https://doi.org/10.1182/blood.V118.21.4201.4201

Published: 2011

Journal Articles

Patients with Lymphoplasmacytic Lymphoma Can Be Salvaged with Autologous Stem Cell Transplantation, Irrespectively of the Number of Previous Treatment Lines. Analysis of 146 Cases from the European Bone Marrow Transplant Registry (EBMT).

Charalampia A. Kyriakou, MD, Anthony H. Goldstone, MD, Anna Sureda, MD, Kwee Yong, PhD, Shirley D’Sa, MD, Goli Taghipour, Carmen Ruiz de Elvira, David C. Linch, MD, PhD, Norbert Schmitz, MD, PhD

Blood (2004) 104 (11): 11.

https://doi.org/10.1182/blood.V104.11.11.11

Published: 2004

NARROW

Neuropathy with IgM Gammopathy: Incidence, Characteristics and Management, a Rory Morrison W.M.U.K Registry Analysis

Bendamustine Plus Rituximab for the Treatment of Waldenström Macroglobulinaemia: Patient Outcomes and Impact of Bendamustine Dosing

High-Dose Methotrexate Based Therapy for the Treatment of Bing Neel Syndrome

Effective Treatment of Cold Agglutinin Disease/Cold Agglutinin Syndrome with Ibrutinib: An International Case Series

Focal, Symptomatic Bone Marrow Lesions in Waldenström Macroglobulinaemia Characterised By Dense Infiltration with Lymphoplasmacytic Lymphoma: A Newly Defined Indication for Systemic Treatment

Whimsical (Waldenstrom's Macroglobulinemia Study Involving CArt-wheeL): A Global Patient-Derived Data Registry Capturing Treatment, Quality of Life and COVID-19 Data

Encouraging Clinical Outcomes for Lymphoma Patients Participating in Early Phase Clinical Trials in the Current Era: A Single Institution and a Global Perspective

Outcomes of Stratification to ASCT or Not Based on Depth of Response: Results of a Phase 2 Trial Assessing the Impact of Minimal Residual Disease (MRD) in Multiple Myeloma Patients with Deferred ASCT (PADIMAC)

Long Term Efficacy, Safety and PK/PD Profile of the Anti-C1s Antibody (BIVV009) in Primary Cold Agglutinin Disease Patients

A Seven Gene Signature to Distinguish Bortezomib- and Lenalidomide-Responsive Myeloma: Rnaseq from the Padimac Study

Whimsical (Waldenström's Macroglobulinemia Study Involving CArt-wheeL): Empowering Patients Internationally to Contribute Patient-Derived Data for Observational Research

Whole Body (WB) MRI in Newly Diagnosed Multiple Myeloma (MM): Fat Fraction Changes at 8 Weeks Predict Response to Induction with Bortezomib Regimens

Subcutaneous PAD As Induction Therapy for Patients with Newly Diagnosed Myeloma: A Phase 2 Trial Assessing the Impact of Minimal Residual Disease (MRD) in Patients with Deferred Autologous Stem Cell Transplantation (PADIMAC)

Single Centre Analysis Of Autologous Stem Cell Transplant Outcomes In Multiple Myeloma In 338 Consecutive Patients: Maintenance/Consolidation Is Associated With Superior Survival, But Early Relapse Is The Single Most Important Predictor Of Survival and May Override Genetic Risk

An Alternate Day Dosing Strategy for Lenalidomide in Multiple Myeloma Improves Cost-Effectiveness Whilst Maintaining Efficacy,

Patients with Lymphoplasmacytic Lymphoma Can Be Salvaged with Autologous Stem Cell Transplantation, Irrespectively of the Number of Previous Treatment Lines. Analysis of 146 Cases from the European Bone Marrow Transplant Registry (EBMT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only